Prevalence and Trends in Systemic Treatment for Pediatric Psoriasis in the USA between 2015 and 2021
In 2020, psoriasis remained relatively uncommon among US children and adolescents, with 15.9% having moderate to severe psoriasis. Meanwhile, treatment for moderate to severe psoriasis shifted from older treatments, particularly non-biologic systemics and TNF inhibitors, toward newer, more efficacious interleukin inhibitors.
Authors
- Amy S. Paller (ORCID: https://orcid.org/0000-0001-6187-6549)
- Anna Ramond (ORCID: https://orcid.org/0000-0002-9958-3693)
- Theresa Rosario-Jansen
- Xinyu Yang (ORCID: https://orcid.org/0009-0002-6036-8942)
Institutions
- Northwestern University (US)
- PAREXEL International (United Kingdom) (GB)
- University of the Latin American Educational Center (AR)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1007/s13555-025-01545-5
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00